Other languages Cynata Therapeutics Limited

Equities

CYP

AU000000CYP7

Market Closed - Australian S.E. Other stock markets 01:36:03 2024-05-23 am EDT			5-day change	1st Jan Change
0.27 ^AUD	0.00%		-3.57%	+116.00%

Apr. 08	Cynata Therapeutics Limited Completes Patient Enrolment in CYP-006TK Diabetic Foot Ulcer Clinical Trial	CI
Apr. 08	Cynata Therapeutics Concludes Patient Enrolment in Diabetic Foot Ulcer Wound Dressing Product Trial	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cynata Therapeutics Limited Completes Patient Enrolment in CYP-006TK Diabetic Foot Ulcer Clinical Trial	Apr. 07
Cynata Therapeutics Concludes Patient Enrolment in Diabetic Foot Ulcer Wound Dressing Product Trial	Apr. 07
Cynata Therapeutics Receives EU Approval for CYP-001 Phase 2 Trial	Mar. 19
Cynata Therapeutics Doses First Patient in Phase Two Trial of Cellular Therapy; Shares Rise 5%	Mar. 04
Cynata Therapeutics Limited Announces Updates on Phase 2 Clinical Trial of CYP-001	Mar. 04
Cynata Therapeutics Names Chief Business Officer; Shares Plunge 14%	Feb. 28
Cynata Therapeutics Limited Announces Initial Data from CYP-006TK Diabetic Foot Ulcer Clinical Trial	Feb. 26
Cynata Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 22
Cynata Therapeutics Expects Initial Results in Diabetic Foot Ulcer Topical Wound Dressing Trial in Q1 2024	Dec. 27
Cynata Therapeutics Secures Approval in Turkey for Phase 2 Trial of HR-aGvHD; Shares Jump 9%	Dec. 07
Cynata Therapeutics Secures Clearance to Advance Phase Three Knee Pain Trial	Nov. 06
Cynata Therapeutics Limited Announces Resignation of David Atkins as Director	23-10-08
Cynata Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-28
Cynata Therapeutics Opens Enrollment for Phase Two Cell Therapy Trial	23-08-10
Cynata Therapeutics Taps COO for CEO/Managing Director Role; Shares Down 4%	23-06-30
Cynata Therapeutics Limited Announces Management Appointments	23-06-29
Cynata Therapeutics Limited Announces Chief Executive Officer Changes	23-06-29
Cynata Therapeutics Completes Oversubscribed Share Purchase Plan	23-05-10
Bolsa de Madrird: Otro momento de la verdad sobre la inflación	23-04-12
Cynata Therapeutics Secures Ethics Approval for Phase Two Trial	23-04-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cynata Therapeutics Limited

Equities

CYP

AU000000CYP7

Other languages

Filters